News

In a collaborative effort Heinz Läubli and co-workers have identified a new potential target to improve T cell activation in immunotherapy.

The researchers focused on the sialoglycan-SAMP/Siglec pathway, in particular on Siglec-9, an inhibitory receptor that is expressed on a broad range of immune cells on which it recognizes sialic acids expressed by tumors. They demonstrate…

Call for applications to the International PhD Program in Biomedicine is open September 1 - October 15

Please check out the details on our website.

The European Research Council has awarded Jan Gründemann an ERC starting grant.

For his research project “Deep brain imaging of cellular mechanisms of sensory processing and learning” the DBM research group leader and SNSF Professor will receive approx. 1.5 million Euro over the next five years. Jan Gründemann's lab…

/ News, Doctorate/PhD

Three DBM MD-PhD students receive a competitive national MD-PhD scholarship.

The Swiss Academy of Medical Sciences (SAMS), the Swiss National Science Foundation (SNSF) and the Swiss Cancer Research Foundation award each year a limited number of competitive three-year MD-PhD scholarships. Repeating the success of…

/ News, Research

A research team led by Prof. Roxane Tussiwand elucidated the cellular origin of plasmacytoid dendritic cells (pDCs).

Their findings, which were recently published in the journal Nature Immunology solve a long standing question about the heterogeneity of pDCs. Using expression profiling of single cells, they identified key transcription factors that are…